Candriam Equities L Oncology Impact R/  LU1864482788  /

Fonds
NAV5/16/2024 Chg.+0.2700 Type of yield Investment Focus Investment company
286.8900USD +0.09% reinvestment Equity Candriam 
     
Chart for Candriam Equities L Oncology Impact R
  Name   ISIN Performance Volatility Sharpe ratio
1. BGF World Healthscience I2 JPY LU2263536315 +27.42% 13.28% 1.78
2. JPM Global Healthcare X (acc) - JPY LU0942618132 +25.24% 13.73% 1.56
3. HSBC GLOBAL INVESTMENT FUNDS - GLOBAL EQUITY SUSTAINABLE HEALTHCARE XCEUR LU2350756875 +19.03% 13.05% 1.17
4. Fidelity Fd.S.Health C.Fd.A Acc HUF LU1273508686 +18.37% 12.68% 1.15
5. KBC Equity Fund - Medical Technologies Classic BE0170813936 +16.23% 11.20% 1.11
6. HSBC GLOBAL INVESTMENT FUNDS - GLOBAL EQUITY SUSTAINABLE HEALTHCARE ACEUR LU2350756529 +17.73% 13.05% 1.07
7. HSBC GIF-Gl.Eq.Sust.Healthcare IC LU2324357396 +18.77% 14.20% 1.05
8. AB SICAV I International Health Care Portfolio Class I LU0251855366 +15.17% 10.81% 1.05
9. AB SICAV I Int.Health Care Pf.A SGD LU0289739699 +14.75% 10.47% 1.05
10. HSBC GIF-Gl.Eq.Sust.Healthcare BC LU2324357123 +18.65% 14.20% 1.04
...
213. Candriam Equities L Oncology Impact R LU1864482788 +7.16% 11.81% 0.28